Informa (LON:INF) Stock Keeps Buy Rating at Berenberg Bank

Informa (LON:INF)‘s stock had its “buy” rating reaffirmed by analysts at Berenberg Bank in a research report issued on Thursday, Marketbeat Ratings reports. They presently have a GBX 1,040 price target on the stock. Berenberg Bank’s price objective would suggest a potential upside of 15.02% from the company’s current price.

INF has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,140 price objective on shares of Informa in a report on Friday, July 31st. Citigroup boosted their target price on Informa from GBX 990 to GBX 1,090 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Finally, JPMorgan Chase & Co. lowered their price target on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Six research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Informa currently has an average rating of “Buy” and an average target price of GBX 1,135.

Informa Trading Up 1.5%

INF stock opened at GBX 904.20 on Thursday. The business has a fifty day moving average price of GBX 893.37 and a 200 day moving average price of GBX 852.74. Informa has a fifty-two week low of GBX 719 and a fifty-two week high of GBX 1,000. The stock has a market capitalization of £11.30 billion, a price-to-earnings ratio of 52.88, a P/E/G ratio of 0.75 and a beta of 0.68. The company has a debt-to-equity ratio of 64.99, a current ratio of 0.55 and a quick ratio of 1.70.

Informa (LON:INF) last announced its earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. Analysts expect that Informa will post 59.3240265 EPS for the current fiscal year.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.